市場調查報告書
商品編碼
1451538
2024-2032 年按產品、最終用戶和地區分類的神經科設備市場報告Neurology Devices Market Report by Product, End User, and Region 2024-2032 |
2023年全球神經科設備市場規模達134億美元。展望未來, IMARC Group預計到2032年市場規模將達到251億美元,2024-2032年複合年成長率(CAGR)為7.1%。
神經病學是一門研究神經系統疾病和失調的醫學科學。神經病學中廣泛使用的設備有多種類型。例如,骶神經刺激裝置透過向位於下背部的目標骶神經發送電脈衝來發揮作用。另一方面,腦脊髓液管理裝置維持腦脊髓液流動並排出大腦中多餘的液體。據此,介入設備使用放射學和導管來診斷中樞神經系統中存在的醫療狀況,而深部腦刺激設備則透過植入向大腦中特定目標區域發送電脈衝的醫療設備來幫助執行手術。這些設備有助於治療複雜的疾病。因此,它們廣泛應用於治療許多神經系統疾病,如強迫症、帕金森氏症、肌張力失調、慢性疼痛、特發性震顫和重度憂鬱症。
該市場主要由醫療保健行業的大幅成長所推動。除此之外,全球範圍內神經系統疾病的日益普及也大大增加了產品需求。老年人口的增加和老年人中風等神經血管疾病發病率的上升進一步推動了神經科設備的採用,從而促進了市場的成長。此外,神經病學設備的持續技術進步和對微創(MI)手術的廣泛需求也是全球範圍內重要的成長誘導因素。推動市場成長的其他一些因素包括不斷擴大的醫療保健支出、全球醫療器材製造商的巨額投資以及神經治療領域的廣泛研發(R&D)。
The global neurology devices market size reached US$ 13.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 25.1 Billion by 2032, exhibiting a growth rate (CAGR) of 7.1% during 2024-2032.
Neurology is a stream of medical science that deals with diseases and disorders of the nervous system. There are numerous types of devices that are widely used in neurology. For instance, sacral nerve stimulation devices function by sending electrical impulses to the targeted sacral nerves located in the lower back. On the other hand, cerebrospinal fluid management devices maintain the cerebrospinal fluid flow and drain excess fluid from the brain. In line with this, interventional devices use radiology and catheters to diagnose the medical conditions present in the central nervous system, whereas deep brain stimulation devices aid in performing procedures by implanting a medical device that sends electrical impulses to specific target areas in the brain. These devices are instrumental in treating complex disorders. As a result, they find widespread applications in the treatment of numerous neurological disorders, such as obsessive-compulsive disorder, Parkinson's disease, dystonia, chronic pain, essential tremor, and major depression.
The market is primarily driven by considerable growth in the healthcare sector. In addition to this, the growing prevalence of neurological disorders across the globe is significantly contributing to the product demand. The increasing geriatric population and the rising incidences of neurovascular conditions, such as stroke, among the elderly are further propelling the adoption of neurology devices, thereby augmenting the growth of the market. Moreover, continual technological advancements in neurology devices and the widespread demand for minimally invasive (MI) surgeries are also acting as significant growth-inducing factors across the globe. Some of the other factors providing an impetus to the market growth include the expanding healthcare expenditure, huge investments made by global medical device manufacturers and extensive research and development (R&D) in the field of neurotherapy.
IMARC Group provides an analysis of the key trends in each sub-segment of the global neurology devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product and end user.
Neurostimulation Devices
Neurosurgery Devices
Interventional Neurology Devices
Cerebrospinal Fluid Management Devices
Others
Hospitals
Ambulatory Surgery Centers
Neurology Clinics
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, B. Braun, Boston Scientific Corporation, Integra LifeSciences, LivaNova PLC, Medtronic plc, Nihon Kohden Corporation, Penumbra Inc. and Stryker Corporation.